Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Colizzi, Marco
McGuire, Philip
Pertwee, Roger G.
and
Bhattacharyya, Sagnik
2016.
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence.
Neuroscience & Biobehavioral Reviews,
Vol. 64,
Issue. ,
p.
359.
Bassir Nia, Anahita
Medrano, Benjamin
Perkel, Charles
Galynker, Igor
and
Hurd, Yasmin L
2016.
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
Journal of Psychopharmacology,
Vol. 30,
Issue. 12,
p.
1321.
O’Neill, Aisling
and
Bhattacharyya, Sagnik
2017.
Investigating the Role of the Endocannabinoid System in Early Psychosis.
Journal of Exploratory Research in Pharmacology,
Vol. 2,
Issue. 3,
p.
85.
Colizzi, Marco
and
Bhattacharyya, Sagnik
2017.
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.
Current Addiction Reports,
Vol. 4,
Issue. 2,
p.
62.
Carol, Emily E.
Spencer, Robert L.
and
Mittal, Vijay A.
2017.
The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.
Psychoneuroendocrinology,
Vol. 83,
Issue. ,
p.
58.
Wijayendran, Surapi Bhairavi
O’Neill, Aisling
and
Bhattacharyya, Sagnik
2018.
The effects of cannabis use on salience attribution: a systematic review.
Acta Neuropsychiatrica,
Vol. 30,
Issue. 1,
p.
43.
Bhattacharyya, Sagnik
Wilson, Robin
Appiah-Kusi, Elizabeth
O’Neill, Aisling
Brammer, Michael
Perez, Jesus
Murray, Robin
Allen, Paul
Bossong, Matthijs G.
and
McGuire, Philip
2018.
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis.
JAMA Psychiatry,
Vol. 75,
Issue. 11,
p.
1107.
Colizzi, Marco
and
Bhattacharyya, Sagnik
2018.
Psychedelic Neuroscience.
Vol. 242,
Issue. ,
p.
179.
Blest-Hopley, Grace
Giampietro, Vincent
and
Bhattacharyya, Sagnik
2018.
Residual effects of cannabis use in adolescent and adult brains — A meta-analysis of fMRI studies.
Neuroscience & Biobehavioral Reviews,
Vol. 88,
Issue. ,
p.
26.
Sami, Musa Basseer
and
Bhattacharyya, Sagnik
2018.
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.
Journal of Psychopharmacology,
Vol. 32,
Issue. 8,
p.
825.
Premkumar, Preethi
Bream, Danielle
Sapara, Adegboyega
Fannon, Dominic
Anilkumar, Anantha P.
Kuipers, Elizabeth
and
Kumari, Veena
2018.
Pituitary volume reduction in schizophrenia following cognitive behavioural therapy.
Schizophrenia Research,
Vol. 192,
Issue. ,
p.
416.
Walter, Emma E.
Fernandez, Francesca
Snelling, Mollie
and
Barkus, Emma
2018.
Stress induced cortisol release and schizotypy.
Psychoneuroendocrinology,
Vol. 89,
Issue. ,
p.
209.
Kaya, Mehmet Cemal
Bulut, Mahmut
Kaplan, İbrahim
and
Gunes, Mehmet
2019.
Levels of endocannabinoid metabolizing enzymes are not related with BDNF levels in patients with schizophrenia: a case-controlled study.
Psychiatry and Clinical Psychopharmacology,
Vol. 29,
Issue. 4,
p.
441.
Jahrami, Haitham
Faris, Mo’ez Al-Islam
Ghazzawi, Hadeel Ali
Saif, Zahra
Habib, Layla
Shivappa, Nitin
and
Hébert, James R.
2019.
Increased Dietary Inflammatory Index Is Associated with Schizophrenia: Results of a Case–Control Study from Bahrain.
Nutrients,
Vol. 11,
Issue. 8,
p.
1867.
Colizzi, Marco
Weltens, Nathalie
McGuire, Philip
Van Oudenhove, Lukas
and
Bhattacharyya, Sagnik
2019.
Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans.
Brain Sciences,
Vol. 9,
Issue. 4,
p.
93.
Labad, Javier
Ortega, Laura
Cabezas, Ángel
Montalvo, Itziar
Arranz, Sara
Algora, Maria José
Solé, Montse
Martorell, Lourdes
Vilella, Elisabet
and
Sánchez-Gistau, Vanessa
2020.
Hypothalamic-pituitary-adrenal axis function and exposure to stress factors and cannabis use in recent-onset psychosis.
The World Journal of Biological Psychiatry,
Vol. 21,
Issue. 7,
p.
564.
Colizzi, Marco
and
Bhattacharyya, Sagnik
2020.
Risk Factors for Psychosis.
p.
305.
Appiah-Kusi, E.
Wilson, R.
Colizzi, M.
Foglia, E.
Klamerus, E.
Caldwell, A.
Bossong, M. G.
McGuire, P.
and
Bhattacharyya, S.
2020.
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids.
Psychological Medicine,
Vol. 50,
Issue. 11,
p.
1862.
Appiah-Kusi, E.
Petros, N.
Wilson, R.
Colizzi, M.
Bossong, M. G.
Valmaggia, L.
Mondelli, V.
McGuire, P.
and
Bhattacharyya, S.
2020.
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
Psychopharmacology,
Vol. 237,
Issue. 4,
p.
1121.
Shum, Carole
Dutan, Lucia
Annuario, Emily
Warre-Cornish, Katherine
Taylor, Samuel E.
Taylor, Ruth D.
Andreae, Laura C.
Buckley, Noel J.
Price, Jack
Bhattacharyya, Sagnik
and
Srivastava, Deepak P.
2020.
Δ9-tetrahydrocannabinol and 2-AG decreases neurite outgrowth and differentially affects ERK1/2 and Akt signaling in hiPSC-derived cortical neurons.
Molecular and Cellular Neuroscience,
Vol. 103,
Issue. ,
p.
103463.